Regulatory Flexibility Act

CIVITAS CAPITAL GROUP SUES USCIS FOR "ASTOUNDING" EB-5 FILING FEE INCREASE

Retrieved on: 
Thursday, April 25, 2024

The lawsuit asks the court to set aside the EB-5 fee increases until USCIS has completed a required fee study and otherwise complied with applicable law.

Key Points: 
  • The lawsuit asks the court to set aside the EB-5 fee increases until USCIS has completed a required fee study and otherwise complied with applicable law.
  • USCIS' rule increased fees for EB-5 filings across the board, failing to even distinguish between costs for large filings versus one-page forms.
  • We will prove this fee is egregious, but at least they're charging it for reviewing a substantive filing," Healy said.
  • Healy, a member of the IIUSA Board of Directors, says this unheard-of USCIS fee increase is unfair to investors, the backbone of the job-creating machine that is the EB-5 program.

ABC Files Lawsuit Against President Biden’s Anti-Competitive Project Labor Agreement Rule for Federal Construction Projects

Retrieved on: 
Thursday, March 28, 2024

ABC’s complaint asserts that President Joe Biden lacks the legal and constitutional authority to impose a new federal regulation injuring economy and efficiency in federal contracting and illegally steering construction contracts to certain unionized contractors, which employ roughly 10% of the U.S. construction workforce.

Key Points: 
  • ABC’s complaint asserts that President Joe Biden lacks the legal and constitutional authority to impose a new federal regulation injuring economy and efficiency in federal contracting and illegally steering construction contracts to certain unionized contractors, which employ roughly 10% of the U.S. construction workforce.
  • ABC estimates the Biden pro-PLA policy will affect at least 180 federal construction contracts valued at $16 billion across America on an annual basis, including several federal construction contracts for projects in Jacksonville and dozens of projects in Florida and the Southeast.
  • “ABC has heard from large and small federal contractors—including firms signatory to union agreements—and concerned federal agency contracting officers that the Biden administration’s controversial PLA policy has already stifled competition and raised costs on federal construction contracts in Florida and across the country.
  • ABC members won 54% of the $205.56 billion in federal contracts worth $35 million or more during fiscal years 2009-2023 and built award-winning projects safely, on time and on budget, without unnecessary government-mandated PLAs.

Monte Silver: Treasury Provides 200,000 Small Business Owners Relief in Final Regulations Issued Under the Tax Cut & Jobs Act

Retrieved on: 
Tuesday, July 14, 2020

"Small businesses are generally invisible to Treasury and the regulatory process, and this advocacy win is the direct result of the smaller business owners standing up and telling Treasury NO MORE!"

Key Points: 
  • "Small businesses are generally invisible to Treasury and the regulatory process, and this advocacy win is the direct result of the smaller business owners standing up and telling Treasury NO MORE!"
  • Recognizing the tremendous burden which GILTI imposed on smaller businesses, Treasury issued proposed regulations that addressed certain aspects of the problem, yet went ever further in the final regulation ," Silver explains.
  • And seeking complete relief from GILTI for small businesses, Silver filed a lawsuit against Treasury for issuing the GILTI regulations in violation of the little-known Federal Regulatory Flexibility Act ("RFA").
  • If your business is impacted by recently published proposed or final regulations of any federal agency, or for media enquiries please contact:

2-Day Course: EU Pharmaceutical Regulations & Strategy (London, United Kingdom - April 29-30, 2019) - ResearchAndMarkets.com

Retrieved on: 
Friday, February 22, 2019

The "EU Pharmaceutical Regulations & Strategy" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "EU Pharmaceutical Regulations & Strategy" conference has been added to ResearchAndMarkets.com's offering.
  • This course will provide an up-to date overview of the European pharmaceutical regulatory environment, procedures and obligations.
  • It will be of value for regulatory affairs personnel and also for those who interact with regulatory personnel in order to understand action timelines and information requirements.
  • This course is for you, particularly if involved in: